{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:36:15Z","timestamp":1768811775503,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Amaz\u00f4nia Fitomedicamentos Ltda","award":["(FITO05\/2012)"],"award-info":[{"award-number":["(FITO05\/2012)"]}]},{"DOI":"10.13039\/100018219","name":"Barretos Cancer Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018219","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2019,4,15]]},"DOI":"10.1007\/s10637-018-0620-y","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T02:14:46Z","timestamp":1529633686000},"page":"223-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells"],"prefix":"10.1007","volume":"37","author":[{"given":"Viviane A. O.","family":"Silva","sequence":"first","affiliation":[]},{"given":"Marcela N.","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"Vera","family":"Miranda-Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Angela M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Aline","family":"Tansini","sequence":"additional","affiliation":[]},{"given":"Adriane F.","family":"Evangelista","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Martinho","sequence":"additional","affiliation":[]},{"given":"Adriana C.","family":"Carloni","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Luiz F.","family":"Pianowski","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-7940","authenticated-orcid":false,"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"issue":"2","key":"620_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/neuonc\/now166","volume":"19","author":"A Miranda-Filho","year":"2017","unstructured":"Miranda-Filho A, Pineros M, Soerjomataram I, Deltour I, Bray F (2017) Cancers of the brain and CNS: global patterns and trends in incidence. Neuro-Oncology 19(2):270\u2013280. https:\/\/doi.org\/10.1093\/neuonc\/now166","journal-title":"Neuro-Oncology"},{"issue":"6","key":"620_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"1","key":"620_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrclinonc.2012.204","volume":"10","author":"S Tanaka","year":"2013","unstructured":"Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J (2013) Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol 10(1):14\u201326. https:\/\/doi.org\/10.1038\/nrclinonc.2012.204","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"620_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1158\/1078-0432.CCR-14-0238","volume":"20","author":"H Ohgaki","year":"2014","unstructured":"Ohgaki H, Burger P, Kleihues P (2014) Definition of primary and secondary glioblastoma--response. Clin Cancer Res 20(7):2013. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-0238","journal-title":"Clin Cancer Res"},{"issue":"7325","key":"620_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nature09557","volume":"468","author":"L Ricci-Vitiani","year":"2010","unstructured":"Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468(7325):824\u2013828. https:\/\/doi.org\/10.1038\/nature09557","journal-title":"Nature"},{"issue":"7325","key":"620_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09624","volume":"468","author":"R Wang","year":"2010","unstructured":"Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468(7325):829\u2013833. https:\/\/doi.org\/10.1038\/nature09624","journal-title":"Nature"},{"issue":"18","key":"620_CR7","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821\u20135828","journal-title":"Cancer Res"},{"key":"620_CR8","doi-asserted-by":"publisher","unstructured":"Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Le Rhun E, Balana C, Chinot O, Bendszus M, Reijneveld JC, Dhermain F, French P, Marosi C, Watts C, Oberg I, Pilkington G, Baumert BG, Taphoorn MJB, Hegi M, Westphal M, Reifenberger G, Soffietti R, Wick W (2017) European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet Oncology 18 (6):e315-e329. doi:https:\/\/doi.org\/10.1016\/s1470-2045(17)30194-8","DOI":"10.1016\/s1470-2045(17)30194-8"},{"issue":"21","key":"620_CR9","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1200\/JCO.2017.72.6737","volume":"35","author":"MJ van den Bent","year":"2017","unstructured":"van den Bent MJ, Smits M, Kros JM, Chang SM (2017) Diffuse infiltrating Oligodendroglioma and astrocytoma. J Clin Oncol 35(21):2394\u20132401. https:\/\/doi.org\/10.1200\/jco.2017.72.6737","journal-title":"J Clin Oncol"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.12688\/f1000research.11493.1","volume":"6","author":"F Lieberman","year":"2017","unstructured":"Lieberman F (2017) Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Research 6:1892. https:\/\/doi.org\/10.12688\/f1000research.11493.1","journal-title":"F1000Research"},{"issue":"10","key":"620_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"6","key":"620_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020849","volume":"6","author":"EC Filippi-Chiela","year":"2011","unstructured":"Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G (2011) Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One 6(6):e20849. https:\/\/doi.org\/10.1371\/journal.pone.0020849","journal-title":"PLoS One"},{"issue":"1","key":"620_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ijc.20856","volume":"115","author":"E Pozo-Guisado","year":"2005","unstructured":"Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Fernandez-Salguero PM (2005) Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 115(1):74\u201384. https:\/\/doi.org\/10.1002\/ijc.20856","journal-title":"Int J Cancer"},{"issue":"3","key":"620_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/01.cmr.0000130007.54508.b2","volume":"14","author":"MP Fuggetta","year":"2004","unstructured":"Fuggetta MP, D'Atri S, Lanzilli G, Tricarico M, Cannavo E, Zambruno G, Falchetti R, Ravagnan G (2004) In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res 14(3):189\u2013196","journal-title":"Melanoma Res"},{"key":"620_CR15","doi-asserted-by":"publisher","unstructured":"Silva VAO, Rosa MN, Tansini A, Oliveira RJ, Martinho O, Lima J, Pianowski LF, Reis RM (2018) In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell lines. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2018.6244","DOI":"10.3892\/etm.2018.6244"},{"issue":"5","key":"620_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11745-001-0750-4","volume":"36","author":"T Akihisa","year":"2001","unstructured":"Akihisa T, Ogihara J, Kato J, Yasukawa K, Ukiya M, Yamanouchi S, Oishi K (2001) Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase. Lipids 36(5):507\u2013512","journal-title":"Lipids"},{"key":"620_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2015.06.051","volume":"303","author":"RC Dutra","year":"2015","unstructured":"Dutra RC, Bicca MA, Segat GC, Silva KA, Motta EM, Pianowski LF, Costa R, Calixto JB (2015) The antinociceptive effects of the tetracyclic triterpene euphol in inflammatory and neuropathic pain models: the potential role of PKCepsilon. Neuroscience 303:126\u2013137. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.06.051","journal-title":"Neuroscience"},{"issue":"4","key":"620_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bcp.2011.11.026","volume":"83","author":"RC Dutra","year":"2012","unstructured":"Dutra RC, de Souza PR, Bento AF, Marcon R, Bicca MA, Pianowski LF, Calixto JB (2012) Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms. Biochem Pharmacol 83(4):531\u2013542. https:\/\/doi.org\/10.1016\/j.bcp.2011.11.026","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"620_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4161\/cbt.11.2.14622","volume":"11","author":"N Chen","year":"2011","unstructured":"Chen N, Karantza V (2011) Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11(2):157\u2013168. https:\/\/doi.org\/10.4161\/cbt.11.2.14622","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"620_CR20","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.fct.2012.05.029","volume":"50","author":"MW Lin","year":"2012","unstructured":"Lin MW, Lin AS, Wu DC, Wang SS, Chang FR, Wu YC, Huang YB (2012) Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1\/2-mediated apoptosis. Food Chem Toxicol 50(12):4333\u20134339. https:\/\/doi.org\/10.1016\/j.fct.2012.05.029","journal-title":"Food Chem Toxicol"},{"key":"620_CR21","doi-asserted-by":"crossref","unstructured":"Martinho O, Silva-Oliveira R, Miranda-Goncalves V, Clara C, Almeida JR, Carvalho AL, Barata JT, Reis RM (2013) In vitro and in vivo analysis of RTK inhibitor efficacy and identification of its novel targets in glioblastomas. Transl Oncol 6 (2):187\u2013196","DOI":"10.1593\/tlo.12400"},{"key":"620_CR22","doi-asserted-by":"publisher","unstructured":"Cruvinel-Carloni A, SilvaOliveira R, Torrieri R, Bidinotto LT, Berardinelli GN, Oliveira-Silva VA, Clara CA, de Almeida GC, Martinho O, Squire JA, Reis RM (2017) Molecular characterization of short-term primary cultures and comparison with corresponding tumor tissue of Brazilian glioblastoma patients. Trans Can Res 6(2):332\u2013345. https:\/\/doi.org\/10.21037\/tcr.2017.03.32","DOI":"10.21037\/tcr.2017.03.32"},{"issue":"3","key":"620_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13402-016-0270-z","volume":"39","author":"RJ Silva-Oliveira","year":"2016","unstructured":"Silva-Oliveira RJ, Silva VA, Martinho O, Cruvinel-Carloni A, Melendez ME, Rosa MN, de Paula FE, de Souza Viana L, Carvalho AL, Reis RM (2016) Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker. Cell Oncol (Dordrecht) 39(3):253\u2013263. https:\/\/doi.org\/10.1007\/s13402-016-0270-z","journal-title":"Cell Oncol (Dordrecht)"},{"issue":"4","key":"620_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.neuropharm.2012.05.008","volume":"63","author":"RC Dutra","year":"2012","unstructured":"Dutra RC, Simao da Silva KA, Bento AF, Marcon R, Paszcuk AF, Meotti FC, Pianowski LF, Calixto JB (2012) Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: the involvement of cannabinoid system. Neuropharmacology 63(4):593\u2013605. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.008","journal-title":"Neuropharmacology"},{"issue":"10","key":"620_CR25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/sj.bjc.6605381","volume":"101","author":"GE Konecny","year":"2009","unstructured":"Konecny GE, Glas R, Dering J, Manivong K, Qi J, Finn RS, Yang GR, Hong KL, Ginther C, Winterhoff B, Gao G, Brugge J, Slamon DJ (2009) Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Br J Cancer 101(10):1699\u20131708. https:\/\/doi.org\/10.1038\/sj.bjc.6605381","journal-title":"Br J Cancer"},{"key":"620_CR26","unstructured":"Suffness M and Pezzuto JM (1990) Assays related to cancer drug discovery. In: Hostettmann K (ed) Methods in plant biochemistry: assays for bioactivity, vol 6. Academic Press, London, pp 71\u2013133"},{"key":"620_CR27","doi-asserted-by":"publisher","unstructured":"Teixeira TL, Oliveira Silva VA, da Cunha DB, Polettini FL, Thomaz CD, Pianca AA, Zambom FL, da Silva Leitao Mazzi DP, Reis RM, Mazzi MV (2016) Isolation, characterization and screening of the in vitro cytotoxic activity of a novel L-amino acid oxidase (LAAOcdt) from Crotalus durissus terrificus venom on human cancer cell lines. Toxicon 119:203\u2013217. doi:https:\/\/doi.org\/10.1016\/j.toxicon.2016.06.009","DOI":"10.1016\/j.toxicon.2016.06.009"},{"issue":"4","key":"620_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/sj.cdd.4401359","volume":"11","author":"T Kanzawa","year":"2004","unstructured":"Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11(4):448\u2013457. https:\/\/doi.org\/10.1038\/sj.cdd.4401359","journal-title":"Cell Death Differ"},{"issue":"2","key":"620_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/neuonc\/nos298","volume":"15","author":"V Miranda-Goncalves","year":"2013","unstructured":"Miranda-Goncalves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Palmeirim I, Reis RM, Baltazar F (2013) Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncology 15(2):172\u2013188. https:\/\/doi.org\/10.1093\/neuonc\/nos298","journal-title":"Neuro-Oncology"},{"issue":"2","key":"620_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/1078-0432.CCR-05-1671","volume":"12","author":"F Bruzzese","year":"2006","unstructured":"Bruzzese F, Di Gennaro E, Avallone A, Pepe S, Arra C, Caraglia M, Tagliaferri P, Budillon A (2006) Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo. Clin Cancer Res 12(2):617\u2013625. https:\/\/doi.org\/10.1158\/1078-0432.ccr-05-1671","journal-title":"Clin Cancer Res"},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul 22:27\u201355. https:\/\/doi.org\/10.1016\/0065-2571(84)90007-4","journal-title":"Adv Enzym Regul"},{"issue":"1\u20133","key":"620_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejphar.2012.10.019","volume":"698","author":"GF Passos","year":"2013","unstructured":"Passos GF, Medeiros R, Marcon R, Nascimento AF, Calixto JB, Pianowski LF (2013) The role of PKC\/ERK1\/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on TPA-induced skin inflammation in mice. Eur J Pharmacol 698(1\u20133):413\u2013420. https:\/\/doi.org\/10.1016\/j.ejphar.2012.10.019","journal-title":"Eur J Pharmacol"},{"issue":"17","key":"620_CR33","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s40265-015-0489-4","volume":"75","author":"M Trendowski","year":"2015","unstructured":"Trendowski M (2015) Recent advances in the development of antineoplastic agents derived from natural products. Drugs 75(17):1993\u20132016. https:\/\/doi.org\/10.1007\/s40265-015-0489-4","journal-title":"Drugs"},{"key":"620_CR34","doi-asserted-by":"publisher","unstructured":"Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28 (18):3061\u20133068. doi:https:\/\/doi.org\/10.1200\/jco.2009.26.7252","DOI":"10.1200\/jco.2009.26.7252"},{"issue":"4","key":"620_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrc2820","volume":"10","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Haber DA, Settleman J (2010) Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 10(4):241\u2013253. https:\/\/doi.org\/10.1038\/nrc2820","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"620_CR36","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3892\/mmr.2013.1650","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Wang G, Yang D, Guo X, Xu Y, Feng B, Kang J (2013) Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression. Mol Med Rep 8(4):1279\u20131285. https:\/\/doi.org\/10.3892\/mmr.2013.1650","journal-title":"Mol Med Rep"},{"issue":"1","key":"620_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1750-3639.2011.00544.x","volume":"22","author":"N Kaza","year":"2012","unstructured":"Kaza N, Kohli L, Roth KA (2012) Autophagy in brain tumors: a new target for therapeutic intervention. Brain Pathol (Zurich, Switzerland) 22(1):89\u201398. https:\/\/doi.org\/10.1111\/j.1750-3639.2011.00544.x","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"3","key":"620_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ijc.24402","volume":"125","author":"SL Lomonaco","year":"2009","unstructured":"Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T, Brodie C (2009) The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer 125(3):717\u2013722. https:\/\/doi.org\/10.1002\/ijc.24402","journal-title":"Int J Cancer"},{"issue":"9","key":"620_CR39","first-page":"2103","volume":"63","author":"T Kanzawa","year":"2003","unstructured":"Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I (2003) Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 63(9):2103\u20132108","journal-title":"Cancer Res"},{"issue":"1","key":"620_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/0100-69912016001005","volume":"43","author":"OJ Santos","year":"2016","unstructured":"Santos OJ, Sauaia Filho EN, Nascimento FR, Junior FC, Fialho EM, Santos RH, Santos RA, Serra IC (2016) Use of raw Euphorbia tirucalli extract for inhibition of ascitic Ehrlich tumor. Revista do Colegio Brasileiro de Cirurgioes 43(1):18\u201321. https:\/\/doi.org\/10.1590\/0100-69912016001005","journal-title":"Revista do Colegio Brasileiro de Cirurgioes"},{"key":"620_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-617","volume":"12","author":"P Zhao","year":"2012","unstructured":"Zhao P, Zhao L, Zou P, Lu A, Liu N, Yan W, Kang C, Fu Z, You Y, Jiang T (2012) Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study. BMC Cancer 12:617. https:\/\/doi.org\/10.1186\/1471-2407-12-617","journal-title":"BMC Cancer"},{"issue":"2","key":"620_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbcan.2010.05.003","volume":"1806","author":"CR LaValle","year":"2010","unstructured":"LaValle CR, George KM, Sharlow ER, Lazo JS, Wipf P, Wang QJ (2010) Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta 1806(2):183\u2013192. https:\/\/doi.org\/10.1016\/j.bbcan.2010.05.003","journal-title":"Biochim Biophys Acta"},{"key":"620_CR43","doi-asserted-by":"publisher","unstructured":"Azoitei N, Kleger A, Schoo N, Thal DR, Brunner C, Pusapati GV, Filatova A, Genze F, M\u00f6ller P, Acker T, Kuefer R, Van Lint J, Baust H, Adler G, Seufferlein T (2011) Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation. Neuro Oncol 13(7):710\u2013724. https:\/\/doi.org\/10.1093\/neuonc\/nor084","DOI":"10.1093\/neuonc\/nor084"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-018-0620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-018-0620-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-018-0620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:29:45Z","timestamp":1678559385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-018-0620-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,15]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1007\/s10637-018-0620-y","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Viviane A O Silva declares that she has conflict of interest. Marcela N Rosa declares that she has conflict of interest. Vera Miranda-Gon\u00e7alves declares that she no has conflict of interest. Angela M Costa declares that she no has conflict of interest. Aline Tansini declares that she no has conflict of interest. Adriane F. Evangelista declares that she no has conflict of interest. Olga Martinho declares that she no has conflict of interest. Adriana C. Carloni declares that she no has conflict of interest. Chris Jones declares that he no has conflict of interest. Jo\u00e3o Paulo Lima declares that he no has conflict of interest. Luiz F Pianowski declares that he has conflict of interest. Rui M Reis declares that he has conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}